Brexit fallout continues with batch testing concerns
Pharmaceutical Technology
AUGUST 12, 2022
Among the negative effects that have been reported are supply chain disruptions, skills shortages, issues around market authorisation, and added costs for pharma CMOs. Even following the Brexit vote, the EU remains the UK’s largest trading partner, and a high proportion of UK drugs originate from European countries.
290 
Let's personalize your content